Home > Analytics > HESTER BIOSCIENCES

HESTER BIOSCIENCES
Intrinsic Value | Fundamental Analysis

BOM : 524669     NSE : HESTERBIO    
LT :  
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive]
Debt : High
Updated:
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Neutral
Price Momentum : Downward
Pledged Shares : None or < 25%
Dec 02,2022
Price(EOD): ₹ 1,864.55
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
Pharmaceuticals & Drugs
MCap: ₹ 1,584.87 Cr
Value of ₹ 1 Lac invested in HESTER BIOSCIENCES
on Dec 04,2017 (price: ₹ 1,246.05)

₹ 1 L

₹ 1.50 L

1W : -3.5% 1M : -6.4% 1Y : -17%
COMMUNITY POLL
for HESTER BIOSCIENCES
Please provide your vote to see the results
HESTER BIOSCIENCES is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Industry Peers & Returns1W1M1Y
HESTER BIOSCIENCES -3.5% -6.4% -17%
SUN PHARMACEUTICAL INDUSTRIES 0.6% -1.1% 38.8%
DIVIS LABORATORIES 0.2% -10.6% -30.7%
DR REDDYS LABORATORIES 2.5% -1% -5.8%
CIPLA 1% -4% 15.8%
GLAND PHARMA -1.3% -8.4% -51.1%
PIRAMAL ENTERPRISES 4.8% 2.6% -64.3%
CADILA HEALTHCARE 4.1% -4.8% -11.6%
TORRENT PHARMACEUTICALS -0.9% -4.3% 7.9%

FUNDAMENTAL ANALYSIS OF HESTER BIOSCIENCES

 
Fundamentals Score
[ Q(TTM): Sep2022, Y: Mar2022
Q : Last Qtr data
Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
]

Insights 💡 HESTERBIO is one of the top 18% companies with good fundamentals ! Discover More →

VALUATION OF HESTER BIOSCIENCES

 
Valuation Score
[As on : Dec 02,2022 ]

Ratio Consolidated
P/E
P/B
P/S
63.59
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs 24.94 Cr
[Latest Qtr - Sep2022 - Consolidated Results ]

6.1
P/B Calculated based on Book Value of Rs 259.99 Cr
[Latest Year - Mar2022 - Consolidated Results ]

6.72
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 236.01 Cr
[Latest Qtr - Sep2022 - Consolidated Results ]

Financial Ratios →

Insights 💡 There are potential 16% undervalued companies ! Discover More →

FAIR VALUE OF HESTER BIOSCIENCES

 
Model Discount(-)/
Premium(+)
EV/EBIDTA
EV/Sales
Price/Sales
403%
228%
275%

Insights 💡 You can learn about various Valuation techniques to calculate Intrinsic Value
with our bestselling video course Value Investing - The Ultimate Guide
Take Me There →

SHARE PRICE MOMENTUM OF HESTER BIOSCIENCES



HESTER BIOSCIENCES vs SENSEX


Insights 💡 You can learn about Basics of Stock Marketing Investing
with our bestselling video course Stock Marketing Investing Simplified
Take Me There →

DEBT OF HESTER BIOSCIENCES

Year Debt/Equity ratio
Standalone Consolidated
2022
2021
2020
Avg_3yrs
0.45
0.07
0.24
0.25
0.86
0.46
0.6
0.64
[Last Annual Data : Mar2022]
Financial Ratios →

PLEDGED PROMOTER SHARES OF HESTER BIOSCIENCES

Pledged Promoter Shares
0 %
As on : Sep2022

If less than 25%

Good
If between 25% and 50% Neutral
If greater than 50% Bad
Shareholding Pattern →

QTRLY RESULTS OF HESTER BIOSCIENCES

Consolidated Q-o-Q Y-o-Y
Revenue
Op Profit
Profit Before Tax
Profit After Tax
44.3%
71.53%
149.46%
203.67%
16.74%
-27.41%
-36.08%
-45.72%
QtrlyTrend
2
Latest Qtr: Sep2022
Quarterly Result Analysis →


HESTER BIOSCIENCES related INDICES

BSE Indices1W1M1Y
S&P BSE MIDSMALLCAP 2.6% 3.1% 7.8%
S&P BSE SMALL CAP 2.4% 3.5% 8.6%
S&P BSE ALLCAP 1.6% 2.7% 9.4%
S&P BSE HEALTHCARE 1.1% -1.6% -6.1%
No NSE index found

You may also like the below Video Courses


FAQ about HESTER BIOSCIENCES


Is HESTER BIOSCIENCES good for long term investment?

As on Dec 02,2022, the Fundamentals of HESTER BIOSCIENCES look Strong and hence it may be good for long term investment! See Financial Performance of HESTER BIOSCIENCES . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!

Is HESTER BIOSCIENCES UnderValued or OverValued?

As on Dec 02,2022, HESTER BIOSCIENCES is Over Valued based on the estimates of intrinsic value and hence may not be a good buying opportunity according to Share Valuation at this time!

What is the Intrinsic Value of HESTER BIOSCIENCES ?

As on Dec 02,2022, the Intrinsic Value of HESTER BIOSCIENCES is Rs. 496.85 estimated based on Median of the 3 historical models.
Fair Value [Median EV / EBIDTA Model] : Rs. 370.99
Fair Value [Median EV / Sales Model] : Rs. 567.70
Fair Value [Median Price / Sales Model] : Rs. 496.85
Estimated Median Fair Value of HESTER BIOSCIENCES : Rs. 496.85

The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.

Is HESTER BIOSCIENCES trading at a Premium or Discount?

As on Dec 02,2022, HESTER BIOSCIENCES is trading at a Premium of 275% based on the estimates of Median Intrinsic Value!

SEBI Research Analyst
The Founder of this website, Mr. Rohit Katiyar is registered with SEBI as a Research Analyst [INH000007377].